España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Tryp Therapeutics Inc Ordinary Shares
TRYPF
OTC
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Tryp Therapeutics Inc Ordinary Shares (TRYPF) Forecast
News
Earnings
Tryp Therapeutics Inc Ordinary Shares (TRYPF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Tryp Therapeutics Inc Ordinary Shares (OTC:TRYPF) Stock
Tryp Therapeutics Inc Ordinary Shares Stock (OTC: TRYPF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 25, 2024
Tryp Therapeutics Set To Finalize Merger With Exopharm, Announces Trading Halt Ahead Of ASX Listing
Patricio Liddle
Friday, January 12, 2024
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Lara Goldstein
Monday, January 08, 2024
Tryp Therapeutics Explores Psilocybin's Potential In New Trials To Treat IBS And Fibromyalgia
Lara Goldstein
Wednesday, July 19, 2023
Psyched: NDAA Amendments Blocked, National Practitioners Network, Marijuana In Jackie Kennedy's Garden And More
Lara Goldstein
Thursday, July 13, 2023
Psilocybin For IBS Gets FDA Nod To Begin Clinical Trials At Mass. General Hospital
Lara Goldstein
Tuesday, June 13, 2023
Silo Pharma's New Ketamine Implant For Fibromyalgia And Chronic Pain Is In The Making
Lara Goldstein
Wednesday, May 24, 2023
Tryp Submits IND Application To FDA For Clinical Trial Of Psilocybin-Assisted Psychotherapy In Patients With IBS
Vuk Zdinjak
Monday, May 01, 2023
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More
Lara Goldstein
Thursday, April 27, 2023
Tryp Therapeutics Secures $1.6M Via Oversubscribed Private Placement
Vuk Zdinjak
Friday, April 14, 2023
EXCLUSIVE: In Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
Joana Scopel
Tuesday, April 04, 2023
Therapists At Mass General Hospital Prepared To Assist IBS Patients With Psilocybin Therapy
Lara Goldstein
Monday, April 03, 2023
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
Javier Hasse
Tuesday, January 10, 2023
Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More
Lara Goldstein
Thursday, January 05, 2023
Treating Binge Eating Disorder With Magic Mushrooms: Phase 2 Clinical Trial Gets Thumbs Up
Lara Goldstein
Tuesday, January 03, 2023
Business & Academia Join Forces To Study Magic Mushroom Therapy For IBS Patients
Lara Goldstein
Tuesday, October 04, 2022
This Psychedelics Company Is Patenting Its Psilocin And Psilocybin Delivery Route
Lara Goldstein
Monday, September 26, 2022
Is Psilocybin Therapy A Potential Treatment For Fibromyalgia & Binge Eating Disorder?
Lara Goldstein
Wednesday, September 14, 2022
Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma
Lara Goldstein
Wednesday, June 15, 2022
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
Natan Ponieman
Friday, June 10, 2022
Clinical Trials Of Psilocybin Treatment For Overeating Disorder Are Ready, Here's What Results Show So Far
Lara Goldstein
Thursday, June 02, 2022
These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry
Natan Ponieman
Monday, May 02, 2022
Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward
Natan Ponieman
Thursday, April 28, 2022
Could Magic Mushrooms Be A Solution For Overeating? New Clinical Trial Intends To Find Out
Natan Ponieman
Thursday, December 23, 2021
FDA Approves Psilocybin For Binge Eating Study By Tryp Therapeutics
Natan Ponieman
Monday, November 08, 2021
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
Natan Ponieman
Monday, October 18, 2021
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Natan Ponieman
Wednesday, October 13, 2021
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Natan Ponieman
Monday, August 30, 2021
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
Natan Ponieman
Thursday, August 26, 2021
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
Benzinga Insights
Ladenburg Thalmann Initiates Coverage On Tryp...
Benzinga Newsdesk
Monday, July 26, 2021
Psyched: Cybin And Field Trip Head To Wall Street, AOC Pushes For Federal Psychedelics Research, Off-Label Ketamine Covered By Insurance In Canada
Natan Ponieman
Monday, July 12, 2021
Psyched: Numinus, MindMed, Cybin Reach Milestones, Harvard To Study Psychedelics Law, Michael Pollan Dives Into Mescaline
Natan Ponieman
